CIEMTO: the new drug and poison research and information center in Medellín, Colombia

"CIEMTO: the new drug and poison research and information center in Medellín, Colombia." Clinical Toxicology, 55(7), pp. 684–685

Disclosure statement

The authors would like to thank all the personnel at CIEMTO, especially all the toxicologists at the University of Antioquia. AFZ has received fees and honoraria for unrelated lectures from Allergan, Amgen, Lilly, Mundipharma, Novo Nordisk, Novartis, Pfizer, Roche and Sanofi. CAR has received fees and honoraria for unrelated lectures from Amgen, Novo Nordisk, Pfizer and Roche. None of these companies or any other pharmaceutical company were involved in the design, execution, or publication of this letter. The other authors declare no conflicts of interest.

Additional information

Funding

CIEMTO was supported by the Sistema General de Regalías de Colombia (BPIN 2013000100183 from the Gobernación de Antioquia), Ruta N and the Universidad de Antioquia UdeA (http://dx.doi.org/10.13039/501100005278). None of these funding bodies were involved in the collection, analysis, and interpretation of data or the writing the manuscript.